Beth Thompson, Chief Strategy Officer at Wellcome responds to Lord Darzi's Independent Investigation of the NHS report
Press release archive
Showing 1 to 20 results of 860
Sorted by most recent
Backing research will contribute to economic growth and lead to advances that improve health.
Nick Moakes to leave "the best investment job in the world" after 17 years.
Wellcome responds to the declaration of Mpox as a 'Public Health Emergency of International Concern' by the World Health Organisation.
Wellcome comments on the government’s proposed changes to planning rules to make it easier to build laboratories, data centres and digital infrastructure and to consult on classifying them as Nationally Significant Infrastructure Projects.
Wellcome CEO John-Arne Røttingen welcomes the next government and sets out our asks for R&D.
Wellcome is calling on the political parties to commit to fulfilling the UK's potential as a global leader in science, research and development (R&D) and innovation.
Wellcome responds to news of a general election.
Joint partnership will support science to tackle a series of global health challenges and build healthier futures, especially for the world’s most vulnerable populations
New Wellcome policy addressing the environmental impact of research, coinciding with environmental sustainability concordat launched by UK research organisations.
Cheryl Moore has decided to leave Wellcome at the end of April after three successful and productive years as Chief Research Programmes Officer.
Wellcome has awarded £17m to 9 different research projects around the world to investigate how extreme heat is impacting maternal and child health.
The Phase 3 clinical trial to assess the efficacy of the M72/AS01E tuberculosis (TB) vaccine candidate is now underway, with first doses given in South Africa, where TB takes a heavy toll. The trial is funded by Wellcome and the Bill & Melinda Gates Foundation.
Wellcome announce funding for 11 transdisciplinary teams across 17 countries to investigate the health impacts of climate change
Wellcome responds to results from a phase III trial of R21/Matrix-M malaria vaccine.
Wellcome's response to the Labour party's plan for the life sciences sector.
Protecting UK from rising heat is matter of life and death: Wellcome response to Environmental Audit Committee report on heat resilience and natural cooling
- New funding scheme to open in Spring 2024 for researchers of Black, Bangladeshi and Pakistani heritage in the UK to advance their careers and improve representation in science.
- Wellcome will also be introducing positive action in shortlisting for its competitive open funding calls and schemes in Spring.
Wellcome’s annual charitable spend in 2022/23 rises to £1.7bn supporting science to improve health and save lives globally
Wellcome responds to the new COP28 deal to transition away from fossil fuels.